These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20192975)

  • 1. Neurological manifestations of antiphospholipid syndrome.
    Rodrigues CE; Carvalho JF; Shoenfeld Y
    Eur J Clin Invest; 2010 Apr; 40(4):350-9. PubMed ID: 20192975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic symptoms as a feature of the antiphospholipid syndrome.
    Miesbach W
    Semin Thromb Hemost; 2008 Apr; 34(3):286-9. PubMed ID: 18720309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological involvement in antiphospholipid antibodies syndrome (APS).
    Amoroso A; Mitterhofer AP; Ferri GM; Galluzzo S; Vadacca M; Afeltra A
    Eur Rev Med Pharmacol Sci; 1999; 3(5):205-9. PubMed ID: 11075618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Non-Criteria' Neurologic Manifestations of Antiphospholipid Syndrome: A Hidden Kingdom to be Discovered.
    Islam MA; Alam F; Kamal MA; Wong KK; Sasongko TH; Gan SH
    CNS Neurol Disord Drug Targets; 2016; 15(10):1253-1265. PubMed ID: 27658514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome.
    Stojanovich L; Kontic M; Smiljanic D; Djokovic A; Stamenkovic B; Marisavljevic D
    Clin Exp Rheumatol; 2013; 31(5):756-60. PubMed ID: 23899875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures.
    Taipa R; Santos E
    Lupus; 2011 Nov; 20(13):1433-5. PubMed ID: 21768180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular manifestations in antiphospholipid syndrome.
    Suvajac G; Stojanovich L; Milenkovich S
    Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology.
    Sanna G; Bertolaccini ML; Hughes GR
    Ann N Y Acad Sci; 2005 Jun; 1051():465-86. PubMed ID: 16126988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurological manifestations of the antiphospholipid syndrome].
    Suárez Alvarez L; Hughes GR; Khamashta MA
    Med Clin (Barc); 2005 Apr; 124(16):630-3. PubMed ID: 15871782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies.
    Chapman J; Rand JH; Brey RL; Levine SR; Blatt I; Khamashta MA; Shoenfeld Y
    Lupus; 2003; 12(7):514-7. PubMed ID: 12892390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral manifestations in the antiphospholipid (Hughes) syndrome.
    Sanna G; D'Cruz D; Cuadrado MJ
    Rheum Dis Clin North Am; 2006 Aug; 32(3):465-90. PubMed ID: 16880079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome.
    Krause I; Lev S; Fraser A; Blank M; Lorber M; Stojanovich L; Rovensky J; Chapman J; Shoenfeld Y
    Ann Rheum Dis; 2005 Oct; 64(10):1490-3. PubMed ID: 15778242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antiphospholipid antibodies in patients with neurological symptoms.
    Miesbach W; Gilzinger A; Gökpinar B; Claus D; Scharrer I
    Clin Neurol Neurosurg; 2006 Feb; 108(2):135-42. PubMed ID: 16412834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome.
    Ganor Y; Goldberg-Stern H; Blank M; Shoenfeld Y; Dobrynina LA; Kalashnikova L; Levite M
    Autoimmunity; 2005 Sep; 38(6):417-24. PubMed ID: 16278146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients.
    Gómez-Puerta JA; Cervera R; Calvo LM; Gómez-Ansón B; Espinosa G; Claver G; Bucciarelli S; Bové A; Ramos-Casals M; Ingelmo M; Font J
    Rheumatology (Oxford); 2005 Jan; 44(1):95-9. PubMed ID: 15367749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-ischemic neurological manifestations in patients with primary antiphospholipid syndrome].
    Kalashnikova LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(2):18-23. PubMed ID: 15792137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus.
    Lampropoulos CE; Koutroumanidis M; Reynolds PP; Manidakis I; Hughes GR; D'Cruz DP
    Arthritis Rheum; 2005 Mar; 52(3):841-6. PubMed ID: 15751063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS").
    Asherson RA
    Autoimmun Rev; 2006 Dec; 6(2):76-80. PubMed ID: 17138247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurological aspects in antiphospholipid syndrome].
    Kitagawa Y
    Rinsho Shinkeigaku; 2003 Nov; 43(11):744-7. PubMed ID: 15152454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.